Literature DB >> 26817478

Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.

Rezaul H Ansary1, Mokhlesur M Rahman2, Mohamed B Awang3, Haliza Katas4, Hazrina Hadi1, Abd Almonen Doolaanea1.   

Abstract

The purpose of this study was to fabricate insulin-loaded double-walled and single-polymer poly(lactide-co-glycolide) (PLGA) microspheres using a fast degrading glucose core, hydroxyl-terminated poly(lactide-co-glycolide) (Glu-PLGA), and a moderate degrading carboxyl-terminated PLGA polymers. A modified water-in-oil-in-oil-in-water (w/o/o/w) emulsion solvent evaporation technique was employed to prepare double-walled microspheres, whereas single-polymer microspheres were fabricated by a conventional water-in-oil-in-water (w/o/w) emulsion solvent evaporation method. The effect of fabrication techniques and polymer characteristics on microspheres size, morphology, encapsulation efficiency, in vitro release, and insulin stability was evaluated. The prepared double-walled microspheres were essentially non-porous, smooth surfaced, and spherical in shape, whereas single-polymer microspheres were highly porous. Double-walled microspheres exhibited a significantly reduced initial burst followed by sustained and almost complete release of insulin compared to single-polymer microspheres. Initial burst release was further suppressed from double-walled microspheres when the mass ratio of the component polymers was increased. In conclusion, double-walled microspheres made of Glu-PLGA and PLGA can be a potential delivery system of therapeutic insulin.

Entities:  

Keywords:  Burst release; Double-walled microspheres; Encapsulation efficiency; Poly(lactide-co-glycolide); Sustained release

Mesh:

Substances:

Year:  2016        PMID: 26817478     DOI: 10.1007/s13346-016-0278-y

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  34 in total

1.  Nanosphere based oral insulin delivery.

Authors:  G P Carino; J S Jacob; E Mathiowitz
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

Review 2.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

3.  Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.

Authors:  G Sharma; C F van der Walle; M N V Ravi Kumar
Journal:  Int J Pharm       Date:  2011-12-30       Impact factor: 5.875

4.  Fabrication of double-walled microspheres for the sustained release of doxorubicin.

Authors:  Eng Chew Tan; Rongyi Lin; Chi-Hwa Wang
Journal:  J Colloid Interface Sci       Date:  2005-06-17       Impact factor: 8.128

5.  A water-in-oil-in-oil-in-water (W/O/O/W) method for producing drug-releasing, double-walled microspheres.

Authors:  Wang Zheng
Journal:  Int J Pharm       Date:  2009-03-24       Impact factor: 5.875

6.  Incorporation of protein in PLG-microspheres with retention of bioactivity.

Authors:  C Sturesson; J Carlfors
Journal:  J Control Release       Date:  2000-07-03       Impact factor: 9.776

7.  Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.

Authors:  Christiane Damgé; Philippe Maincent; Nathalie Ubrich
Journal:  J Control Release       Date:  2006-10-25       Impact factor: 9.776

8.  Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres.

Authors:  C Presmanes; L de Miguel; R Espada; C Alvarez; E Morales; J J Torrado
Journal:  J Microencapsul       Date:  2011-10-03       Impact factor: 3.142

9.  A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres.

Authors:  H Sah
Journal:  J Pharm Sci       Date:  1997-11       Impact factor: 3.534

10.  Localization of bovine serum albumin in double-walled microspheres.

Authors:  N A Rahman; E Mathiowitz
Journal:  J Control Release       Date:  2004-01-08       Impact factor: 9.776

View more
  1 in total

1.  An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics.

Authors:  Youssef W Naguib; Brittany E Givens; Giang Ho; Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder; Aliasger K Salem
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.